Regulatory framework in healthcare
Key Sources of Healthcare Funding
Consolidated Public Expenditure on Healthcare
Government Policy and Targets in Healthcare (May Presidential Decrees)
Contents
Government Program and National Project in Healthcare
Government Program “Development of Healthcare”
National project: Long and Active Life
National project: New Technologies for Preserving Health
Maternity and Childhood Protection
Development of Pediatric Care and Modernizing of Infrastructure
Governance of the Healthcare System
Federal Center for Drug Supply
Center for Assessment and Monitoring of Care Delivery
Centre for Expert Evaluation of Medicinal Products
Russian Research Institute of Health (RIH)
Healthcare Committee of the State Duma
Ministry of Industry and Trade
Public-Private Partnership in Healthcare
Eurasian Economic Union: Brief overview
EAEU: Background and governing bodies
EAEU: Establishing a single pharmaceutical market
Rules for Registration and Examination of Medicines
Changes and special measures in the circulation and registration of medicines in the EAEU
Regulatory Instruments in Healthcare
Procedure for Compilation of Federal Drug Lists
Changes to the Procedure for Compilation of Federal Drug Lists and MAA
Procedure for Drug Inclusion into Federal Drug Lists
State regulation of drug prices
Procedure for Registration of Max Selling Price for EDL Drugs
Specifics related to regulation of maximum sale price for EDL drugs
Strategy for Developing Drug Provision and Pharmaceutical Industry
New Models of Pharmaceutical Reimbursement (Pilot Projects)
Strategy for development of pharmaceutical industry
Program for Support of Domestic Pharmaceutical and Medical Industry
Program for Support of Domestic Pharmaceutical and Medical Industry for the period 2022-2024
Government Program Industrial Development and Increasing Competitiveness
Programs That Govern Development of Domestic Pharmaceutical Industry
Public Provision of Pharmaceuticals
Drug Supply Programs: Brief Overview
Changes Planned for Reimbursement Segment
Public Spending on Pharmaceuticals, By Program
Prescribing and Procurement of Drugs not Included in EDL and Other Lists
Prescribing and Procurement of Drugs Based on the Decision of the Clinic Medical Board
VZN: Provision of Patients with Costly Pharmaceuticals
Public Drug Procurement in Russia
Regulation for Public Drug Procurement
Procedures for supplier determination
Maximum Starting Contract Price
Special Drug Procurement Regulation
Preferences in Public Tenders Based on the Degree of Product Localization
Covid-19: impact on economy and healthcare system
Government measures to support national economy
Government Measures to Support the Healthcare System
Key Trends in the Russian Healthcare
Import substitution and support for domestic pharmaceutical production
Improving administration and regulation of health care
Improving the care delivery system
Improving the drug supply and reimbursement system
Changes to the rules for inclusion of new medical products to reimbursable drug lists